Top 10 Companies in the Riboflavin Kinase Market (2026): Market Leaders Powering Global Nutrition

The Global Riboflavin Kinase Market was valued at USD 724 million in 2023 and is projected to reach USD 1,125.09 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.50% during the forecast period (2025–2032). This growth trajectory highlights the increasing demand for riboflavin and its active forms in various industries, fueled by growing awareness regarding the importance of Vitamin B2 in human health and wellness.

As the nutrition and pharmaceutical industries evolve toward more sustainable and health‑centric products, the spotlight is on the key players who are driving innovation, efficiency, and cleaner supply chains. In this blog, we profile the Top 10 Companies in the Riboflavin Kinase Market—a mix of global vitamin leaders, chemical innovators, and biopharmaceutical pioneers shaping the future of nutrition and metabolic health.

---

Riboflavin Kinase Market – View in Detailed Research Report

Market Insight

Riboflavin Kinase is an essential enzyme involved in the metabolism of riboflavin, or Vitamin B2. This enzyme is vital for the conversion of riboflavin into its active coenzyme forms: flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). These coenzymes play crucial roles in the body’s ability to metabolize carbohydrates, fats, and proteins, which ultimately produce energy and support cellular processes, such as oxygen utilization.

In the broader context, Riboflavin Kinase is instrumental in the synthesis of enzymes that impact energy production, making it an essential element in nutrition and metabolism. This market refers to the global demand, supply, and application of Riboflavin Kinase in various sectors, including food additives, animal feeding, pharmaceuticals, health supplements, and cosmetics.

Market Size

The global Riboflavin Kinase market was valued at approximately USD 724 million in 2023. The market is anticipated to expand significantly, with a projected compound annual growth rate (CAGR) of 6.50%, reaching USD 1,125.09 million by 2032. North America’s Riboflavin Kinase market size was estimated at USD 188.65 million in 2023. The market in this region is forecast to grow at a CAGR of 5.57% through the forecast period from 2025 to 2032, driven by rising health awareness, growing demand for supplements, and increasing pharmaceutical applications.

Top 10 Companies in the Riboflavin Kinase Market

1️⃣ 1. DSM

Headquarters: Heerlen, Netherlands
Key Offering: Riboflavin, Riboflavin Kinase, Nutritional Ingredients

DSM is a global leader in health, nutrition, and biosciences, producing high‑quality riboflavin and riboflavin kinase for food additives, pharmaceuticals, and animal feed. Their integrated bioprocessing platform ensures consistent supply and high purity.

Sustainability & Growth Initiatives:

• Biotechnological production of riboflavin to reduce carbon footprint.
• Partnerships with food‑grade manufacturers to expand fortified food markets.
• Investment in research for novel coenzyme applications in metabolic disorders.

2️⃣ 2. BASF

Headquarters: Ludwigshafen, Germany
Key Offering: Riboflavin derivatives, Chemical Innovations

BASF leverages its chemical expertise to develop riboflavin derivatives that enhance stability and bioavailability, catering to the pharmaceutical and cosmetic sectors.

Sustainability & Growth Initiatives:

• Development of green chemistry processes for vitamin synthesis.
• Strategic alliances with cosmetic brands for skin‑health formulations.
• Scaling up production capacity to meet rising global demand.

3️⃣ 3. NB Group

Headquarters: Nanjing, China
Key Offering: Riboflavin, Riboflavin Kinase, Animal Nutrition

NB Group is a leading vitamin manufacturer in Asia, providing riboflavin kinase for both human health and animal feed, with a focus on quality and regulatory compliance.

Sustainability & Growth Initiatives:

• Adoption of sustainable sourcing of raw materials.
• Expansion into emerging markets such as Southeast Asia and India.
• Collaboration with research institutes to explore new therapeutic applications.

4️⃣ 4. Shanghai Acebright Pharmaceuticals

Headquarters: Shanghai, China
Key Offering: Riboflavin Kinase for Human Health & Animal Feed

Shanghai Acebright specializes in pharmaceutical‑grade riboflavin kinase, supporting drug development in metabolic disorders and providing high‑purity enzyme for animal nutrition.

Sustainability & Growth Initiatives:

• Investment in GMP facilities to ensure product safety.
• Partnerships with global pharma companies for co‑development projects.
• Implementation of waste‑reduction programs in manufacturing.

5️⃣ 5. Hubei Guangji Pharmaceutical

Headquarters: Wuhan, China
Key Offering: Riboflavin-Based Products, Enzyme Solutions

Hubei Guangji focuses on the development and production of riboflavin‑derived enzymes, delivering solutions for both human therapeutics and livestock nutrition.

Sustainability & Growth Initiatives:

• Research into low‑energy bioprocessing techniques.
• Expansion of product portfolio into nutraceuticals.
• Collaboration with universities for innovative enzyme discovery.

6️⃣ 6. Ningxia Qiyuan Pharma

Headquarters: Yinchuan, China
Key Offering: Riboflavin Kinase for Animal Feed

Ningxia Qiyuan is emerging as a key player in the animal feed market, providing riboflavin kinase to enhance livestock growth and health.

Sustainability & Growth Initiatives:

• Development of cost‑effective fermentation processes.
• Strategic alliances with feed manufacturers.
• Focus on quality assurance and traceability.

7️⃣ 7. Hebei Shengxue Dacheng

Headquarters: Shijiazhuang, China
Key Offering: Riboflavin Production, Enzyme Manufacturing

Hebei Shengxue Dacheng specializes in large‑scale riboflavin production, supplying both the food and pharmaceutical industries.

Sustainability & Growth Initiatives:

• Implementation of renewable energy in production plants.
• Partnerships with food‑additive companies.
• Investment in R&D for new coenzyme applications.

8️⃣ 8. Xinfa Pharmaceutical

Headquarters: Shanghai, China
Key Offering: Riboflavin, Riboflavin Kinase, Nutraceuticals

Xinfa Pharmaceutical delivers riboflavin kinase for health supplements and pharmaceutical formulations, emphasizing high purity and bioavailability.

Sustainability & Growth Initiatives:

• Adoption of green chemistry for enzyme synthesis.
• Expansion into emerging markets in Africa and South America.
• Collaboration with nutraceutical firms for product innovation.

9️⃣ 9. Astellas Pharma

Headquarters: Tokyo, Japan
Key Offering: Riboflavin Kinase in Metabolic Disorder Therapies

Astellas Pharma integrates riboflavin kinase into its pipeline for metabolic disease treatments, focusing on enhancing cellular energy production.

Sustainability & Growth Initiatives:

• Investment in clinical trials for enzyme‑based therapies.
• Partnerships with biotechnology firms for advanced manufacturing.
• Commitment to reducing environmental impact of drug production.

🔟 10. GSK

Headquarters: London, United Kingdom
Key Offering: Riboflavin Kinase in Pharmaceutical Formulations

GSK leverages riboflavin kinase in its drug development portfolio, particularly for metabolic and cardiovascular disorders.

Sustainability & Growth Initiatives:

• Focus on sustainable sourcing of raw materials.
• Collaboration with academic institutions for enzyme research.
• Implementation of circular economy principles in production.

---

Download FREE Sample Report: Riboflavin Kinase Market – View in Detailed Research Report

Get Full Report: Riboflavin Kinase Market – View in Detailed Research Report

Outlook: The Future of Riboflavin Kinase

The Riboflavin Kinase market is undergoing a dynamic shift. While traditional applications in food additives and animal feed remain strong, the industry is investing billions in biotechnological advancements, sustainable production methods, and expanding applications in pharmaceuticals and cosmetics.

Key Trends Shaping the Market:

• Rapid expansion of bioprocessing technologies to reduce production costs.
• Regulatory push for higher purity standards in pharmaceutical and cosmetic uses.
• Increasing consumer demand for vitamin‑enriched functional foods and supplements.
• Strategic alliances between vitamin producers and global pharma companies.

Forecast: The market base year is 2025, with an estimated value for 2026 and a forecast for 2034. The projected CAGR of 6.50% indicates robust growth, especially in emerging markets such as Asia‑Pacific and South America.